Israel Englander Novartis Ag Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Novartis Ag stock. As of the latest transaction made, Millennium Management LLC holds 40,193 shares of NVS stock, worth $4.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,193

Previous 210,700 80.92%

Holding current value

$4.14 Million

Previous $22.4 Million 79.39%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $3.33 Million - $3.79 Million	31,330 Added 353.49%	40,193 $4.62 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $24.3 Million - $28.2 Million	-262,380 Reduced 96.73%	8,863 $943,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $12.1 Million - $13.8 Million	-127,057 Reduced 31.9%	271,243 $26.2 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $31.3 Million - $34.4 Million	339,146 Added 573.33%	398,300 $40.2 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $82.2 Million - $93.2 Million	-888,068 Reduced 93.76%	59,154 $5.97 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $74.8 Million - $86.7 Million	934,095 Added 7115.83%	947,222 $87.1 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $1.43 Million - $1.75 Million	-18,939 Reduced 59.06%	13,127 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $1.97 Million - $2.3 Million	26,412 Added 467.14%	32,066 $2.44 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $24.9 Million - $28.9 Million	-308,670 Reduced 98.2%	5,654 $478,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $42.3 Million - $47.9 Million	-528,345 Reduced 62.7%	314,324 $27.6 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $4.53 Million - $5.01 Million	56,802 Added 7.23%	842,669 $73.7 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $54.6 Million - $63.5 Million	667,519 Added 564.03%	785,867 $64.3 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $5.43 Million - $6 Million	63,675 Added 116.47%	118,348 $10.8 Million
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $2.01 Million - $2.37 Million	24,114 Added 78.91%	54,673 $4.67 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $8.36 Million - $10.1 Million	-107,089 Reduced 77.8%	30,559 $2.89 Million
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $60 Million - $66.5 Million	-730,454 Reduced 84.14%	137,648 $12 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $10.3 Million - $11.6 Million	127,132 Added 17.16%	868,102 $75.8 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $52.4 Million - $73.4 Million	740,970 New	740,970 $61.1 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $30.1 Million - $33.2 Million	-352,466 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $1.22 Million - $1.5 Million	-16,146 Reduced 4.38%	352,466 $32.2 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $48.2 Million - $59.4 Million	-639,893 Reduced 63.45%	368,612 $33.1 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $34.4 Million - $39.4 Million	457,201 Added 82.93%	1,008,505 $97 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $62.2 Million - $69.2 Million	-843,870 Reduced 60.48%	551,304 $47.3 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $33.9 Million - $39.2 Million	505,951 Added 56.9%	1,395,174 $120 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $6.31 Million - $7.13 Million	-97,189 Reduced 9.85%	889,223 $67.2 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $34.1 Million - $40.8 Million	484,738 Added 96.62%	986,412 $79.8 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $24 Million - $25.8 Million	-331,861 Reduced 39.81%	501,674 $42.1 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $61.8 Million - $64.4 Million	833,535	833,535 $71.6 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account